Ireland's economy likely to withstand potential Trump policy impacts

Capital Economics analysis indicates Ireland's economy is well-positioned to withstand potential risks from U.S. policy changes, despite close economic ties. The report suggests U.S. tariffs on pharmaceuticals would have limited impact due to diversified export destinations, and while U.S. tax policy changes could affect GDP and corporate tax revenues, key indicators like Modified Domestic Demand (MDD) and employment would be less impacted. Ireland's strong fiscal position, marked by a budget surplus and low debt, further insulates it, with Capital Economics projecting continued MDD growth exceeding 2% annually, significantly outperforming the Eurozone.

Analysis

A recent analysis by Capital Economics indicates that Ireland's economy is well-positioned to manage potential macroeconomic shocks from U.S. policy changes. Despite the U.S. accounting for 30% of Irish goods exports, the impact of potential tariffs is expected to be muted, particularly in the key pharmaceutical sector, as over half of these exports are directed to other global markets. Furthermore, the sector is projected to retain its international competitiveness even with new trade barriers. While shifts in U.S. tax policy could diminish Ireland's appeal for multinational tax optimization, potentially lowering headline GDP and corporate tax revenues, the core domestic economy appears insulated. Key indicators such as Modified Domestic Demand (MDD) and employment are forecasted to be significantly less affected. This resilience is underpinned by a strong fiscal position, characterized by a large budget surplus and a low debt burden, providing a substantial cushion against a potential decline in corporate tax receipts. Ireland's domestic economy has already demonstrated superior performance, with MDD growth significantly outpacing the euro-zone since the pandemic. Capital Economics projects this trend will continue, forecasting an average annual growth rate of over 2% for Ireland through 2030, compared to approximately 1% for the rest of the euro-zone.

Key Decisions for Investors

• Investors should consider that Ireland's economic fundamentals and projected growth of over 2% annually suggest a resilient outlook, potentially justifying an overweight position in Irish assets relative to the broader Eurozone.
• When evaluating the Irish economy, prioritize domestically-focused indicators like Modified Domestic Demand (MDD) and employment figures over headline GDP, which can be distorted by the activities of multinational corporations.
• While potential changes to U.S. tax policy present a risk to Irish corporate tax revenue, the country's strong budget surplus and low debt provide a significant buffer, suggesting the risk is manageable rather than critical.
• The analysis points to the robustness of Ireland's export sector, particularly pharmaceuticals, which demonstrates strategic diversification beyond the U.S. market, mitigating risks from potential protectionist trade policies.